OsTend: A load-bearing, bi-phasic collagen scaffold for massive rotator cuff repairs
OsTend: A load-bearing, bi-phasic collagen scaffold for massive rotator cuff repairs
批准号:
10761321
负责人:
Subba Shankar
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-07-31
关键词:
AddressAnimal ModelArticular Range of MotionBiocompatible MaterialsBone GrowthBone RegenerationCharacteristicsChronicClinicalCollagenContralateralCytoskeletonDefectDepositionDermalDistalFutureHistologicHistologyHydroxyapatitesImplantIndustrializationInfiltrationLeftLegal patentLicensingLimb structureMacrophageMechanicsMesenchymal Stem CellsModelingMuscleNatural regenerationOperative Surgical ProceduresOryctolagus cuniculusOsteogenesisOutcomeOutcome MeasurePainPatientsPhasePhenotypeProceduresProcessPropertyReplacement ArthroplastyRotator CuffShapesSheepShoulderSideSiteSurgeonSurgical ModelsSurgical suturesTechnologyTendon structureTestingTimeTissuesWeight-Bearing statebiomaterial compatibilityboneclinically relevantcollagen scaffoldcostcost estimatecrosslinkdensitydesigndisabilityeffective therapyfeasibility testinggenipinhigh rewardhigh riskimprovedin vivoinfraspinatous musclemanufacturemedical implantmicroCTmimicrynovelpreclinical studyreconstitutionregenerativerepairedrotator cuff tearscaffoldscale upstem cells
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1 Summary:
2 There are ~300,000 rotator cuff (RC) repair procedures performed in the US annually at an estimated cost of
3 $4B. Advanced degeneration of the RC causes pain and major disability. ‘Massive’ or ‘Irreparable’ (> 5 cm) tears
4 of RC consist of detachment between bone & tendon, and degeneration of tendon; thus, they cannot be repaired
5 arthroscopically. Representing 40% of RC tears, they require costly and invasive muscle transfer or arthroplasty
6 procedures. Overlay patches, dermal and otherwise, at best passively reinforce the underlying tendon and do
7 not contribute to regeneration of tendon nor the enthesis. There is an unmet clinical need to develop regenerative
8 implant products for patients suffering from irreparable tears.
9 CollaMedix Inc. develops biotextile medical implants using high-strength pure-collagen threads produced by our
10 patented process of high-throughput electrochemical compaction. Spooled threads manufactured at CollaMedix
11 are braided by industrial braiding machines to obtain macroporous, highly biocompatible, resorbable scaffolds.
12 Collagen molecules are unidirectionally aligned within the scaffold threads, mimicking the native topography of
13 tendon, and imparting a tenoinductive effect on stem cells, as evidenced by the expression of tendon-specific
14 marker tenomodulin. Host collagen is templated parallel to these threads, resulting in an ordered tissue
15 deposition. Also, the crosslinking agent genipin that is used to stabilize threads polarizes macrophages to a pro-
16 regenerative phenotype.
17 We have designed such a scaffold that is infused with hydroxyapatite at one end, making it osteo-inductive on
18 that side while remaining teno-inductive on the other. This bi-phasic OsTend scaffold is load-bearing and
19 suturable, so it can bridge a large bone-tendon gap, while integrating with both bone and tendon. These
20 properties are ideal for repairing massively torn, degenerated tendons.
21 Based on this significant promise, CollaMedix Inc. proposes to test the feasibility of OsTend in a rabbit
22 model of chronic RC degeneration and repair. Rabbit infraspinatus tendons will be transected, allowed to
23 degenerate, and repaired with OsTends or left un-repaired. At 4 and 12 weeks post-implant, the tendons will be
24 mechanically tested and processed for histology. We hypothesize that the OsTend repaired group will have
25 stronger, thicker tendons and more normal histological characteristics, approaching that of intact controls.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collagen-based tissue guidance biofabric for treatment of stress urinary incontinence
-
批准号:10010584
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2020
-
负责人:Subba Shankar
-
依托单位:
海外基金